학술논문
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
Document Type
Article
Author
Cristea, Mihaela C.; Stewart, Daphne; Synold, Timothy; Ruel, Nora; Mortimer, Joanne; Wang, Edward; Jung, Alexander; Wilczynski, Sharon; Konecny, Gottfried E.; Eng, Melissa; Kilpatrick, Lindsay; Han, Ernest; Dellinger, Thanh; Hakim, Amy; Lee, Stephen; Morgan, Robert J.; Wakabayashi, Mark T.; Frankel, Paul H.
Source
In Gynecologic Oncology March 2024 182:124-131
Subject
Language
ISSN
0090-8258